Dr. William C. Holvik, MD

Dr. Holvik practices at Holvik Family Health Center in Visalia, California.

Dr. Holvik's NPI, 1346225364, was assigned on December 13, 2005. Dr. Holvik graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1990. Dr. Holvik holds California license G72459.

Dr. Holvik's primary practice is Holvik Family Health Center, at 221 E Caldwell Ave, Visalia, CA 93277-7605. The practice phone is (559) 732-4726.

Dr. Holvik's primary practice is Holvik Family Health Center in Visalia, California. Dr. Holvik is also affiliated with Kaweah Health Medical Center. The medical group on file is Holvik Family Health Center. Dmand AI also links Dr. Holvik to 1 more hospital, 5 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holvik practices, 8 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Holvik's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Holvik is licensed in California.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, aneurysm, anxiety, arthritis, asthma and atrial fibrillation and flutter among the conditions Dr. Holvik treats.

CMS data shows 2,244 Medicare services from Dr. Holvik across 20 procedure codes in 2024, for 507 Medicare patients. Medicare paid $147,674 for them. Every service was in an office.

CMS counts 507 Medicare patients who saw Dr. Holvik in 2024. The largest group is 65 to 74, with 258 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Holvik's median patient age at 57, with 52% women.

In 2024, Dr. Holvik wrote 14,297 Medicare Part D claims for 1,032 patients. 89% of them were for generic drugs. CMS names the drug for 13,537 of them, across 173 drugs with 11 or more claims each, at $1,083,956 in total drug cost. In 2023, CMS named 10,806 claims across 157 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 21 out of 100 for Dr. Holvik for performance year 2024, reported individually. Dr. Holvik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Holvik as offering telehealth. CMS counts 18 procedures of removal of skin lesions by Dr. Holvik, more than 64% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,369 general payments to Dr. Holvik from 74 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $1,817.

Dr. Holvik graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1990.

Dr. Holvik is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.